Sofregen Medical
Cambridge, US · Founded 2014
Biotech
Founders & leadership
MK
Milan KofolExecutive Officer
DS
Doug SheldonDirector
AH
Anh HoangExecutive Officer
HW
Howard WeismanExecutive Officer, Director
AN
Amir NashatDirector
Reported raises · per SEC filings
Form D private placements$8.1MraisedSep 2019 · 3 investors · Biotechnology
Rule 506(b)$9.7MraisedSep 2017 · 7 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.